Martin Shkreli
In September 2015, Shkreli received widespread criticism when Turing got the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56 (from $13.50 to $750 per pill), leading him to be referred to as "the most hated man in America" and "pharma bro".